Amyloidosis: Clinical Trials

1 trial for Amyloidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Enrolling by invitation 1

Follow Amyloidosis: new trials by email Literature Review of Amyloidosis trials Research Report on Amyloidosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET Imaging With [18F]Fluselenamyl in People With Cardiac Amyloidosis
[18F]Fluselenamyl (FSA) - Cardiac Amyloidosis
Phase 1Enrolling by invitationWashington University School of Medicine502026-01-142026-08-18

Narrower conditions

Amyloid Neuropathies, Familial (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)

Broader conditions

Amyloid Neuropathies (1)  ·  Amyloidosis, Familial (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphoproliferative Disorders (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Plasma Cell (1)  ·  Nervous System Diseases (1)

Sponsors

Washington University School of Medicine (1)

Countries

United States (1)